EUVIMEDEUVIMED entdecken
Crossref

Enhancing predictive accuracy for antidepressant response in depressive disorders: The additive value of interleukin-1β and interleukin-6 alongside hsCRP

Jae-Min Kim, Hee-Ju Kang, Ju-Wan Kim, Min Jhon, Ju-Yeon Lee, Sung-Wan Kim, Il-Seon Shin

Journal of Affective Disorders · 2025

DOI: 10.1016/j.jad.2024.12.091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Jae-Min Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Chonnam National University Medical School, Gwangju, Republic of Korea. Electronic address: jmkim@chonnam.ac.kr. Hauptthemen laut MEDLINE: Interleukin-6, Interleukin-1beta, C-Reactive Protein, Antidepressive Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: This study aimed to evaluate the potential additive effects of measuring serum interleukin-1 beta (IL-1β) and interleukin-6 (IL-6) on enhancing the predictive value of baseline serum high-sensitivity C-reactive protein (hsCRP) levels for predicting 12-week antidepressant treatment responses in patients with depressive disorders. METHODS: Serum levels of hsCRP, IL-1β, and IL-6 were measured at baseline in 1086 outpatient participants diagnosed with depressive disorders. Participants initially received monotherapy with antidepressants for the first three weeks, followed by a naturalistic, stepwise pharmacotherapy regimen administered every three weeks up to 12 weeks. Remission was defined as achieving a score of ≤7 on the Hamilton Depression Rating Scale. Logistic regression models were employed to analyze the data, adjusting for demographic and clinical covariates. RESULTS: Higher baseline levels of hsCRP, IL-1β, and IL-6 were significantly associated with lower rates of remission at 12 weeks. Notably, the inclusion of IL-1β and IL-6 levels alongside hsCRP significantly enhanced the model's predictive accuracy, revealing robust interaction effects among these biomarkers. LIMITATION: Serum biomarkers were solely measured at baseline and various antidepressants in stepwise psychopharmacotherapy should be considered. CONCLUSION: The addition of IL-1β and IL-6 measurements to hsCRP testing could significantly refine the prediction of antidepressant treatment outcomes. These findings support the integration of multiple inflammatory markers into clinical practice, advancing personalized medicine approaches in the treatment of depressive disorders. Further replication studies and randomized controlled trials are encouraged to validate and extend these preliminary findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-6Interleukin-1betaC-Reactive ProteinAntidepressive AgentsDepressive DisorderMajor Depressive DisorderHumansMaleFemaleAdultMiddle AgedBiomarkersTreatment OutcomePredictive Value of Tests

Stichwörter der Autor:innen

AntidepressantDepressionInflammationPredictionRemission

Substanzen

Interleukin-6Interleukin-1betaC-Reactive ProteinAntidepressive AgentsBiomarkers

Autor:innen und Institutionen

  • Department of Psychiatry, Chonnam National University Medical School, Gwangju, Republic of Korea. Electronic address: jmkim@chonnam.ac.kr.
  • Department of Psychiatry, Chonnam National University Medical School, Gwangju, Republic of Korea.
  • Department of Psychiatry, Chonnam National University Medical School, Gwangju, Republic of Korea; Mental Health Clinic, Chonnam National University Hwasun Hospital, Hwasun, Republic of Korea.

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Kim, J. M., Kang, H. J., Kim, J. W., Jhon, M., Lee, J. Y., Kim, S. W., & Shin, I. S. (2025). Enhancing predictive accuracy for antidepressant response in depressive disorders: The additive value of interleukin-1β and interleukin-6 alongside hsCRP. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.12.091

Vancouver

Kim JM, Kang HJ, Kim JW, Jhon M, Lee JY, Kim SW, et al. Enhancing predictive accuracy for antidepressant response in depressive disorders: The additive value of interleukin-1β and interleukin-6 alongside hsCRP. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2024.12.091

BibTeX
@article{Kim2025,
  author = {Kim, Jae-Min and Kang, Hee-Ju and Kim, Ju-Wan and Jhon, Min and Lee, Ju-Yeon and Kim, Sung-Wan and Shin, Il-Seon},
  title = {Enhancing predictive accuracy for antidepressant response in depressive disorders: The additive value of interleukin-1β and interleukin-6 alongside hsCRP},
  journal = {Journal of Affective Disorders},
  year = {2025},
  doi = {10.1016/j.jad.2024.12.091}
}
Kostenlos starten →